Utility of heart-type fatty acid binding protein as a new biochemical marker for the early diagnosis of acute coronary syndrome

Journal of Clinical and Diagnostic Research

Volumn 9, Issue 1, 2015, Pages BC22-BC24

  Gami, Bhakti N ^a   Patel, Dharmik S ^b   Haridas, N ^c   Chauhan, Kiranp P ^d   Shah, Hitesh ^c   Trivedi, Amit ^c  

^a All India Institute of Medical Sciences   (India)

^b Gujarat Adani Institute of Medical Sciences   (India)

^c PRAMUKHSWAMI MEDICAL COLLEGE   (India)

^d GMERS Medical College   (India)

Author keywords

Biomarker; High sensitive troponin T; Myocardial infarction

Indexed keywords

FATTY ACID BINDING PROTEIN; TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; ANGIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; Q WAVE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; THORAX PAIN; THROMBUS;

EID: 84924855843     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2015/11006.5451     Document Type: Article

References (23)

1. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb. 2005;12(6):295–300. doi: 10.5551/jat.12.295.
2. Cho CM, Lee YM. The relationship between cardiovascular disease risk factors and gender. Health. 2012;4:309-15.
3. H Katus, J Searle, E Giannitsis. “How to Use High-Sensitivity Cardiac Troponins in Acute Cardiac Care?” Conference Papers in Medicine, vol. 2013, Article ID 162831, 4 pages, 2013. doi:10.1155/2013/162831.
4. Xu RY, Zhu XF, Yang Y, Ye P. High-sensitive cardiac troponin T. J Geriatr Cardiol. 2013;10:102-09.
5. Thygesen K, Mair J, Giannitsis E, et al. Study Group on Biomarkers in Cardiology of ESC Working Group on Acute Cardiac Care. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J. 2012;33(18):2252–57.
6. Azzazy HM, Pelsers MM, Christenson RH. Unbound free fatty acids and heart type fatty acid-binding protein: diagnostic assays and clinical applications. Clin Chem. 2006;52:19-29.
7. Glatz JF, van der Vusse GJ. Cellular fatty acid-binding proteins: their function and physiological significance. Prog Lipid Res. 1996;35(3):243–82. doi: 10.1016/ S0163-7827(96)00006-09.
8. Storch J, Thumser AE. The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta. 2000;1486:28–44.
9. Ishii J, Wang JH, Naruse H, Taga S, Kinoshita M, Kurokawa H, et al. Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem. 1997;43:1372–78
10. Okamoto F, Sohmiya K, Ohkaru Y, Kawamura K, Asayama K, Kimura H, et al. Human heart type cytoplasmic fatty acid binding protein fort he diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB. Clin Chem Lab Med. 2000;38(3):231–38.
11. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60:1581–98.
12. Wodzig KW, Pelsers MM, van der Vusse GJ, Roos W, Glatz JF. One-step enzyme-linked immunosorbent assay (ELISA) for plasma fatty acid-binding protein. Ann Clin Biochem. 1997;34:263–68.
13. Apple FS, Murakami M, Panteghini M, et al. International survey on the use of cardiac markers. Clinical Chemistry. 2001;47(3):587–88.
14. Apple FS, Quist HE, Otto AP, Mathews WE, Murakami MM. Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin Chem.2002;15:1097–100.
15. Kim KS, Lee HJ, Kim K, Jo YH, Kim TY, Lee JH, et al. Heart-type fatty acid binding protein as an adjunct to cardiac troponin-I for the diagnosis of myocardial infarction. J Korean Med Sci. 2011;26:47–52.
16. Body R, McDowell G, Carley S, Wibberley C, Ferguson J, Mackway-Jones K. A FABP-ulous ‘rule out’ strategy? Heart fatty acid binding protein and troponin for rapid exclusion of acute myocardial infarction. Resuscitation. 2011;82:1041–46.
17. McMahon CG, Lamont JV, Curtin E, McConnell RI, Crockard M, Kurth MJ, et al. Diagnostic accuracy of heart-type fatty acid-binding protein for the early diagnosis of acute myocardial infarction. Am J Emerg Med. 2012;30(2):267–74.
18. Ruff CT, Bonaca MP, Kosowsky JM, Conrad MJ, Murphy SA, Jarolim P, et al. Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study. J Thromb Thrombolysis. 2013;36(4): 361-67.
19. Kurz K, Giannitsis E, Becker M, Hess G, Zdunek D, Katus HA. Comparison of the new high sensitive cardiac troponin T with myoglobin, h-FABP and cTnT for early identification of myocardial necrosis in the acute coronary syndrome. Clin Res Cardiol. 2011;100:209–15.
20. Inoue K, Suwa S, Ohta H, et al. Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain. Circ J. 2011;75(12):2813–20.
21. Reiter M, Twerenbold R, Reichlin T, Mueller M, Hoeller R, Moehring B, et al. Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction. Heart. 2013;99:708–14.
22. Shortt CR, Worster A, Hill SA, Kavsak PA. Comparison of hs-cTnI, hs-cTnT, hFABP and GPBB for identifying early adverse cardiac events in patients presenting within six hours of chest pain-onset. Clin Chim Acta. 2013;419:39-41.
23. Seino Y, Tomita Y, Takano T, Ohbayashi K. Tokyo Rapid-Test Office Cardiologists (Tokyo-ROC) Study. Office cardiologists cooperative study on whole blood rapid panel tests in patients with suspicious acute myocardial infarction: comparison between heart-type fatty acid-binding protein and troponin T tests. Circ J. 2004;68:144–48.